Gene Query: LSM8

Dataset Description Geneva Score
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 27.66
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 26.63
RNA sequencing of BT142 and TS603 cell lines 26.63
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 24.21
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 21.71
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 21.28
Transcriptome analysis of U87 cells upon LINC00152 knockdown 21.02
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 19.71
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 15.87
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 15.62
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 15.24
Global analysis of enhancer targets: Mosaic-seq 14.53
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 13.83
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 13.34
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 13.1
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 12.71
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 12.71
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 12.18
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 12.18
HNF1A deficiency impairs β-cell fate, granule maturation and function 12.09
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 12.06
SLAM-seq for K562 endogenous mRNA decay 11.6
Seletive inhibition of CDK9 in DLBCL cell lines 11.33
CROP-Seq in Primary Human T Cells 11.1
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 11.1
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 11.0
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 10.33
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 10.2
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 10.1
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 9.99
Transcriptome analysis of SKI knock-out in HL60 cells 9.99
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 9.97
Generating Patterned Kidney Organoids for Studying Development and Diseases 9.94
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 9.87
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.31
Human cell line and subcutaneous tumor 9.23
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 9.18
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 9.18
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 9.14
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.04
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 8.97
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 8.76
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 8.39
Mapping interactions for the TNIP2 hub protein 8.1
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 8.04
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 7.93
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 7.89
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 7.89
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.77
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 7.67
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 7.58
Effect of PRDM11 depletion in U2932 cells 7.41
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 7.37
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 7.37
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 7.26
Transcriptional profiles of normal human mature B cells 7.15
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 7.13
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.13
miRNAs affected by antagomiR-17 treatment 7.12
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 7.05
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.98
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 6.98
Cleavage Factor Im as a key regulator of 3’ UTR length 6.88
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.86
Single-cell analysis of human kidney organoids 6.83
Identification of renal resident macrophages across species 6.76
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 6.73
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 6.56
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 6.53
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 6.53
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 6.49
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 6.49
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.43
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.38
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.38
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 6.36
A practical evaluation of alignment algorithms for RNA variant calling analysis 6.32
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.22
Transcriptional responses of melanoma cells to BRAF inhibition 6.11
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.07
Peptidomimetic blockade of MYB in acute myeloid leukemia 6.04
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 6.04
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 6.02
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.97
RNA-Seq with and without RNase treatment in PCa cell lines 5.94
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.93
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.89
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 5.86
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.85
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.53
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.53
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 5.5
Knockdown of ADNP in HCT116 colon cancer cells 5.5
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.48
Transcriptional profiling of LS1034 cells treated with tepoxalin 5.41
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.39
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.35
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.34
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.33
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.33
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 5.28
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 5.28
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 5.27
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.25
The comparison of high-throughput single-cell RNA-seq methods 5.25
Gene expression profiling of leukemia cells following asparagine depletion 5.23
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 5.22
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 5.19
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 5.18
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 5.18
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 5.16
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 5.16
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.14
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 5.08
m6A-dependent regulation of messenger RNA stability 5.05
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 5.0
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 4.91
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 4.91
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 4.85
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 4.84
Transcriptomic analyssis following EHMT1/2 inhibition 4.84
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 4.82
LIN28A Over-expression RNAseq 4.81
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 4.81
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 4.78
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.77
Transcriptomic analysis of human tonsillar TFH subsets 4.74
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 4.72
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 4.64
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 4.61
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 4.6
ETV7 and interferon response 4.53
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 4.53
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.52
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.46
Targeting MTHFD2 in Acute Myeloid Leukemia 4.36
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.34
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 4.34
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 4.33
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 4.32
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 4.32
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 4.32
Transcriptional profiling of microglia; current state of the art and future perspectives 4.26
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.25
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 4.24
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 4.23
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 4.21
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.21
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 4.2
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 4.2
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 4.16
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 4.16
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.14
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 4.12
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.11
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 4.05
Regulation of protein translation during mitosis 4.04
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 4.03
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.01
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 4.01
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 3.98
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.95
Co-regulation of splicing by Rbfox1 and hnRNP M 3.94
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.94
Tracking distinct RNA populations using efficient and reversible covalent chemistry 3.93
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 3.89
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 3.89
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 3.88
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.87
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.87
Unique features and clinical importance of acute alloreactive immune responses 3.84
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 3.83
PRDM1 inhibits proliferation of human colon cancer organoids 3.83
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.82
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 3.8
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 3.79
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 3.79
O-glcnAc reprograms cellular energetics 3.79
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.78
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 3.78
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 3.76
Regulation of highly expressed hCINAP on translatome 3.75
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 3.75
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.74
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 3.72
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 3.72
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.7
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.7
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 3.68
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.67
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.67
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 3.66
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.66
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.66
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 3.66
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 3.65
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 3.65
MYC dependent mRNA translation shapes gene expression and cell biology 3.65
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 3.61
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 3.6
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 3.6
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 3.6
Neurofibroma 3.59
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 3.59
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 3.59
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.54
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.5
Gene expression signatures of innate lymphoid cells from human blood 3.49
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.48
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 3.47
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 3.47
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 3.45
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.45
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.44
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.41
Genome-wide chromatin analysis of Ewing sarcoma 3.41
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 3.38
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.38
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 3.37
Androgen Receptor-regulated genes in prostate cancer cells 3.37
Systematic discovery of endogenous human ribonucleoprotein complexes 3.37
HEK293 TFAM Knockout Expression Study 3.37
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.37
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.35
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.35
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.34
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 3.34
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.32
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.32
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.3
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.3
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.29
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 3.27
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.22
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.22
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.22
mRNA expression profile of Lymphocytes 3.21
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 3.2
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 3.2
quanTIseq: quantifying immune contexture of human tumors 3.2
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.16
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.15
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.15
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 3.13
PTHrP overexpression in MCF7 cells 3.12
Patient-derived xenograft platform for metastatic melanoma 3.07
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 3.07
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 3.06
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 3.06
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.04
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.04
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.0
Transcriptome analysis of BAP1 knockout and restoration 3.0
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 3.0
Exploring ILF2 regulatory genes by next-generation sequencing 3.0
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 2.98
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.97
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.97
RNA sequencing with KSHV infection and enrichment for circular RNAs 2.97
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 2.96
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.93
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.93
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.91
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.9
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.87
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 2.87
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 2.86
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.85
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 2.79
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.75
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.75
HNRNPM-regulated splicing dependencies in prostate cancer 2.75
MeRIP-seq for heat shock in B-cell lymphoma cells 2.74
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.71
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 2.71
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.68
RNA polymerase in pre-B-ALL cell lines 2.64
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.63
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.63
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 2.62
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 2.59
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 2.58
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 2.58
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 2.55
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.54
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.52
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.5
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.5
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.5
Gene expression in GBM with Cav3.2 inhibition 2.49
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.47
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.46
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.42
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.42
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.4
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.39
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.38
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 2.38
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.37
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 2.36
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.34
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.32
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.32
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.32
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.3
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 2.29
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.27
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.27
Capturing the Interactome of Newly Transcribed RNA 2.25
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.25
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.22
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.22
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.21
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.21
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.17
EWS-Fli and LNC regulated genes in comparison to GFP samples 2.16
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 2.15
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.14
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 2.13
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.12
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.11
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.09
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.06
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 2.04
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.02
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 2.02
An optimization system for isolating and sequencing of single human colon cancer cells 2.01
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.99
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.96
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.95
RNA-seq analyisis of PUM2 knockout cells 1.95
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 1.93
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.91
scRNASeq analysis of cycling cardiomyocytes 1.89
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 1.88
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.88
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.88
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 1.87
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 1.87
Global Mapping of Human RNA-RNA Interactions 1.86
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.85
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.83
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.83
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.79
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.79
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.78
RNA sequencing of human mammary epithelial cells 1.78
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.78
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.77
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.75
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.73
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.7
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.7
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.67
Role of COP1 on MAP kinase transcriptional output in melanoma 1.67
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.67
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.66
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.65
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.64
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.62
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.59
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.59
Human Treg IFNg/IL-10 subpopulations 1.58
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.55
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.55
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.54
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.5
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.47
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 1.47
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 1.45
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 1.45
Transcriptome sequencing of K-562 cells 1.42
BASP1 modifies the Tamoxifen response 1.4
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.39
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.37
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 1.34
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.34
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.32
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.31
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.31
Human Treg NaCl stimulation 1.28
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.28
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.25
Human Treg IL-12 stimulation 1.21
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.21
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.2
Effect of ILF3 on translation during homeostasis and the antiviral response 1.19
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.18
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.17
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.15
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.14
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.13
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.13
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.09
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.09
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.08
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.08
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.06
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.04
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 1.03
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.0
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.99
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.99
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.98
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.97
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.97
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 0.91
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.85
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.84
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.84
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.84
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.84
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.83
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.82
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.81
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.81
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.8
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.79
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.79
Gene expression analysis in response to hypoxic pathway inhibition 0.78
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.78
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.75
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.75
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 0.74
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.73
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.73
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.73
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.72
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.68
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.66
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.66
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.64
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.63
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.62
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.62
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 0.62
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.56
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.55
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.54
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.53
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.53
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.52
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.51
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.51
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.51
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.48
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.45
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.45
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.44
Genome-wide analysis of the Integrator complex 0.35
Genome-wide analysis of the Integrator complex (HTS) 0.35
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.34
High-resolution comparative analysis of great ape genomes 0.33
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.33
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.33
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.31
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.31
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.28
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.27
Transcriptome-wide modulation of splicing by the exon junction complex 0.26
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.26
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.25
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.25
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.25
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.24
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.24
mRNA recovered upon RNF219 IP. [RNA-IP] 0.21
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 0.19
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.18
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.18
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.18
Aging-associated patterns in the expression of human endogenous retroviruses 0.17
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.17
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.16
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.16
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.15
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.14
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.13
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.12
Role of cervicovaginal microbiota in genital inflammation 0.12
RNA seq analysis of human Fetal and adult derived Enterospheres 0.12
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.11
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.11
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.11
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.1
Interphase condensins regulate ligand-depedent enhancer activation 0.1
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.1
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.1
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.09
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.09
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.09
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 0.06
SNHG5 siRNA knock down in HCT116 cells 0.05
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.05
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.05
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.05
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.05
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.02
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.02
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation